• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

72
26
21
15
11

COUNTRY

26
4
4
2
2

CATEGORIES

  • 188
  • 93
  • 91
  • 47
  • 41
  • 38
  • 38
  • 22
  • 19
  • 9
  • 9
  • 7
  • 5
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

149
358
489
588

PUBLISHED

8
22
90
588

PRODUCT TYPE

355
230
2

Search "Breast Cancer Therapy Area Pipeline Report" returned 588 results.

PRODUCT TITLE
Drug Delivery in Cancer - Technologies, Markets and Companies Drug Delivery in Cancer - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

March 2015
FROM
Gene Therapy - Technologies, Markets and Companies Gene Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

March 2015
FROM

Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players

GBI Research, the leading business intelligence provider, has released its latest research, ""Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars...

April 2013
FROM

Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake

GBI Research, the leading business intelligence provider, has released its latest research “Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival,...

March 2013
FROM
Oncology Intelligence: A Comprehensive Report for Decision Making Oncology Intelligence: A Comprehensive Report for Decision Making - Product Thumbnail Image

Oncology Intelligence: A Comprehensive Report for Decision Making

Oncology Intelligence Report 2013 provides complete landscape on cancer drug development, by bringing more authentic data under evaluation and is designed in a manner to keep knowledge instant, clear...

January 2013
Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing breast cancer drug development Find out whether you are number one, two or further down the ladder...

August 2012
FROM
Avastin (Breast Cancer) - Analysis and Forecasts to 2020 Avastin (Breast Cancer) - Analysis and Forecasts to 2020 - Product Thumbnail Image

Avastin (Breast Cancer) - Analysis and Forecasts to 2020

Avastin (Breast Cancer) – Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Avastin (Breast Cancer) – Analysis and Forecasts to 2020” provides Avastin sales estimates for...

December 2011
FROM
Xeloda (Breast Cancer) - Analysis and Forecasts to 2020 Xeloda (Breast Cancer) - Analysis and Forecasts to 2020 - Product Thumbnail Image

Xeloda (Breast Cancer) - Analysis and Forecasts to 2020

Xeloda (Breast Cancer) – Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Xeloda (Breast cancer) - Analysis and Forecasts to 2020” provides Xeloda sales forecasts for US,...

December 2011
FROM

Gemzar (Breast Cancer) - Analysis and Forecasts to 2020

Gemzar (Breast Cancer) - Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Gemzar (Breast Cancer) – Analysis and Forecasts to 2020” provides Gemzar sales estimates for US,...

December 2011
FROM
Taxol (Breast Cancer) - Analysis and Forecasts to 2020 Taxol (Breast Cancer) - Analysis and Forecasts to 2020 - Product Thumbnail Image

Taxol (Breast Cancer) - Analysis and Forecasts to 2020

Taxol (Breast Cancer) – Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Taxol (Breast Cancer) – Analysis and Forecasts to 2020” provides Taxol sales estimates for US,...

December 2011
FROM
Taxotere (Breast Cancer) - Analysis and Forecasts to 2020 Taxotere (Breast Cancer) - Analysis and Forecasts to 2020 - Product Thumbnail Image

Taxotere (Breast Cancer) - Analysis and Forecasts to 2020

Taxotere (Breast Cancer) – Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Taxotere (Breast Cancer) – Analysis and Forecasts to 2020” provides Taxotere sales estimates...

December 2011
FROM
Cancer Therapeutics - Market Insight and R&D Pipeline Analysis Cancer Therapeutics - Market Insight and R&D Pipeline Analysis - Product Thumbnail Image

Cancer Therapeutics - Market Insight and R&D Pipeline Analysis

Objectives and Scope The intention of this study is to provide a detailed and thorough analysis of the present and future global market for cancer therapeutics This report analyzes in detail the markets...

August 2008
FROM

Afatinib (Breast Cancer) - Analysis and Forecasts to 2020

Afatinib (Breast Cancer) - Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Afatinib (Breast Cancer) - Analysis and Forecasts to 2020” provides Afatinib sales estimates...

December 2011
FROM
Herceptin (Breast Cancer) - Analysis and Forecasts to 2020 Herceptin (Breast Cancer) - Analysis and Forecasts to 2020 - Product Thumbnail Image

Herceptin (Breast Cancer) - Analysis and Forecasts to 2020

Herceptin (Breast Cancer) – Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Herceptin (Breast Cancer) – Analysis and Forecasts to 2020” provides Herceptin sales estimates...

December 2011
FROM
Aromasin (Breast Cancer) - Analysis and Forecasts to 2020 Aromasin (Breast Cancer) - Analysis and Forecasts to 2020 - Product Thumbnail Image

Aromasin (Breast Cancer) - Analysis and Forecasts to 2020

Aromasin (Breast Cancer) – Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Aromasin (Breast cancer) - Analysis and Forecasts to 2020” provides Aromasin sales forecasts...

December 2011
FROM
Femara (Breast Cancer) - Analysis and Forecasts to 2020 Femara (Breast Cancer) - Analysis and Forecasts to 2020 - Product Thumbnail Image

Femara (Breast Cancer) - Analysis and Forecasts to 2020

Femara (Breast Cancer) – Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Femara (Breast Cancer) – Analysis and Forecasts to 2020” provides Femara sales estimates for US,...

December 2011
FROM
Halaven (Breast Cancer) - Analysis and Forecasts to 2020 Halaven (Breast Cancer) - Analysis and Forecasts to 2020 - Product Thumbnail Image

Halaven (Breast Cancer) - Analysis and Forecasts to 2020

Halaven (Breast Cancer) – Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Halaven (Breast cancer) - Analysis and Forecasts to 2020” provides Halaven sales forecasts for...

December 2011
FROM
Abraxane (Breast Cancer) - Analysis and Forecasts to 2020 Abraxane (Breast Cancer) - Analysis and Forecasts to 2020 - Product Thumbnail Image

Abraxane (Breast Cancer) - Analysis and Forecasts to 2020

Abraxane (Breast Cancer) – Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Abraxane (Breast Cancer) – Analysis and Forecasts to 2020” provides Abraxane sales forecasts...

December 2011
FROM
Omnitarg (Breast Cancer) - Analysis and Forecasts to 2020 Omnitarg (Breast Cancer) - Analysis and Forecasts to 2020 - Product Thumbnail Image

Omnitarg (Breast Cancer) - Analysis and Forecasts to 2020

Omnitarg (Breast Cancer) – Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Omnitarg (Breast Cancer) – Analysis and Forecasts to 2020” provides Omnitarg sales estimates...

December 2011
FROM
Nolvadex (Breast Cancer) - Analysis and Forecasts to 2020 Nolvadex (Breast Cancer) - Analysis and Forecasts to 2020 - Product Thumbnail Image

Nolvadex (Breast Cancer) - Analysis and Forecasts to 2020

Nolvadex (Breast Cancer) – Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Nolvadex (Breast cancer) - Analysis and Forecasts to 2020” provides Nolvadex sales forecasts...

December 2011
FROM
Loading Indicator

Our Clients

NBC Universal Inc. Samsung Group Ltd. E.ON SE DHL International GmbH University of Cambridge Kone Oyj BP Plc.